Merck & Co., Inc.

Portfolio Overview

The filing for Merck & Co., Inc. (CIK: 0000310158) reveals a highly specialized, non-diversified investment portfolio with a distinct focus on the biotechnology sector. As of the reporting period ending September 30, 2025, the total portfolio value stood at approximately $171.31 million, spread across just 8 holdings. This represents a significant contraction in capital, with the portfolio value decreasing by 20.5% from the previous quarter's $215.60 million. ...